Skip to main content
IDEX Biometrics ASA logo

IDEX Biometrics ASA — Investor Relations & Filings

Ticker · IDEX ISIN · NO0013107490 LEI · 5967007LIEEXZXHECW11 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,325 across all filing types
Latest filing 2021-08-20 Regulatory Filings
Country NO Norway
Listing OL IDEX

About IDEX Biometrics ASA

https://www.idexbiometrics.com/

IDEX Biometrics ASA is a technology company specializing in fingerprint identification and biometric authentication solutions. The company designs, develops, and commercializes proprietary fingerprint sensors and software for integration into smart cards. Its core products are biometric payment cards and access cards, which provide enhanced security for financial transactions and identity verification. The technology stores and matches the user's fingerprint data directly on the card, ensuring that sensitive biometric information is never stored in the cloud. This on-card approach enables secure and convenient authentication with a simple touch, replacing traditional PINs and passwords. The solutions are certified by major payment networks like Visa and Mastercard and are compliant with FIDO standards for strong online authentication, offering protection against phishing and other cyber threats for both payment and access control systems.

Recent filings

Filing Released Lang Actions
IDEX Biometrics Receives an Order for its TrustedBioT Sensor
Regulatory Filings Classification · 99% confidence The document is a short press release dated August 20, 2021, announcing that IDEX Biometrics has received an 'additional purchase order' for its TrustedBio sensors from an existing customer. This is a specific operational update regarding a commercial transaction and production backlog, not a comprehensive financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). It is a general business update that doesn't fit neatly into the highly specific categories like Capital (CAP) or M&A (TAR). Given the nature of the announcement—a specific, non-financial operational event—it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory or significant operational announcements that aren't covered by the other specific codes. Since the document length is short and it is a direct announcement rather than a link to a larger report, RNS is the most appropriate classification.
2021-08-20 English
IDEX Biometrics Presentation for the First Half of 2021
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Interim Report for First Half 2021' and contains detailed financial summaries, including a Profit & Loss statement for Q2 2021 and prior periods. It also includes strategic investment highlights, product launch details, and market analysis. While it contains presentation-style slides, it functions as a comprehensive interim financial report for the company, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-12 English
IDEX Biometrics Presentation for the First Half of 2021
Regulatory Filings Classification · 99% confidence The document is titled "IDEX Biometrics Presentation for the First Half of 2021" and explicitly states that the company "has prepared an updated Company Presentation for the first half year of 2021." It then directs the reader to a webcast and notes that the "presentation slide deck is attached, as a PDF file, at the end of this release." This structure—a short announcement describing the release of a presentation deck—fits the definition of a Report Publication Announcement (RPA). It is not the full presentation (IP) or a comprehensive financial report (IR/10-K), but rather the notice about its availability. The short length (1888 chars) also supports the 'MENU VS MEAL' rule pointing towards RPA.
2021-08-12 English
IDEX Biometrics ASA releases Interim Report for the First Half of 2021
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT FOR FIRST HALF 2021' and contains detailed financial results, including revenue, operating expenses, net loss, and cash flow analysis for the period ending June 30, 2021. It also includes a 'CEO's Comments' section and a 'First Half Review' section. Since it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2021
2021-08-12 English
IDEX Biometrics ASA releases Interim Report for the First Half of 2021
Report Publication Announcement Classification · 95% confidence The document is an announcement from IDEX Biometrics ASA regarding the release of its interim financial results for the first half of 2021. While it contains summary financial highlights (revenue, operating expenses, net loss), it explicitly states that the full report is to be filed with the Financial Supervisory Authority in Norway and provides a link to the company's website to access the full report. According to the 'Menu vs Meal' rule, this is an announcement of a report rather than the full interim report itself, making it a Report Publication Announcement (RPA). H1 2021
2021-08-12 English
Grant of Incentive Subscription Rights in IDEX Biometrics 11 August 2021
Remuneration Information Classification · 99% confidence The document announces the grant of 'incentive subscription rights' to employees and executives, detailing the number of rights, exercise price, vesting schedule, and the total outstanding rights. It specifically mentions grants to primary insiders (CEO, CFO, CTO). This type of announcement, dealing with the issuance of options or rights related to company shares, falls under Capital/Financing Update (CAP) as it directly impacts the capital structure and employee compensation schemes tied to equity. It is not a Director's Dealing (DIRS) because it is a grant from the company, not a personal transaction by the director, nor is it a general Share Issue (SHA) which usually refers to a public offering or major capital change, although there is overlap. Given the focus on incentive rights/options, CAP is the most appropriate fit among the provided options, as it relates to financing/capital structure mechanisms.
2021-08-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.